CoChat

Mitochondrial Dysfunctions: A Red Thread across Neurodegenerative Diseases

Open access
Stanga, Serena, Caretto, Anna, Boido, Marina, Vercelli, Alessandro · 2020 · International Journal of Molecular Sciences

The DOI matches its Crossref record; 242 of the 244 references it cites were found in a registry or an index.

Abstract

Mitochondria play a central role in a plethora of processes related to the maintenance of cellular homeostasis and genomic integrity. They contribute to preserving the optimal functioning of cells and protecting them from potential DNA damage which could result in mutations and disease. However, perturbations of the system due to senescence or environmental factors induce alterations of the physiological balance and lead to the impairment of mitochondrial functions. After the description of the crucial roles of mitochondria for cell survival and activity, the core of this review focuses on the “mitochondrial switch” which occurs at the onset of neuronal degeneration. We dissect the pathways related to mitochondrial dysfunctions which are shared among the most frequent or disabling neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and Huntington’s, Amyotrophic Lateral Sclerosis, and Spinal Muscular Atrophy. Can mitochondrial dysfunctions (affecting their morphology and activities) represent the early event eliciting the shift towards pathological neurobiological processes? Can mitochondria represent a common target against neurodegeneration? We also review here the drugs that target mitochondria in neurodegenerative diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms21103719

Cites

242 of 242 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 The mitochondrial switch. The sketch shows the appearance and the features of a mitochondrion before and after the accumulation of damage responsible for its impairment. At the onset of the neurodegenerative process the increase of reactive oxygen species (ROS), mitochondrial DNA (mtDNA) mutations and altered proteins determines the swelling of mitochondria and the disruption of their membranes and cristae. Such an altered morphology heavily impacts on function determining, among others, decreases ATP production, increased ROS, leading to neuronal death. Created with BioRender software.
Figure 1 The mitochondrial switch. The sketch shows the appearance and the features of a mitochondrion before and after the accumulation of damage responsible for its impairment. At the onset of the neurodegenerative process the increase of reactive oxygen species (ROS), mitochondrial DNA (mtDNA) mutations and altered proteins determines the swelling of mitochondria and the disruption of their membranes and cristae. Such an altered morphology heavily impacts on function determining, among others, decreases ATP production, increased ROS, leading to neuronal death. Created with BioRender software.CC BY · PubMed Central
Figure 2 The process of neurodegeneration in the central nervous system (CNS), in the periphery and across diseases. Neurodegeneration is a progressive process taking place not only in the CNS but also in the periphery. After the accumulation of damage at the cellular and, in particular, mitochondrial level, the switch from physiology to pathology is fast and rarely reversible and it is occurring in many cell types. Indeed, it occurs in the CNS but also in the periphery, in particular the neuromuscular junction (NMJ), the skeletal muscles, blood cells, and fibroblasts. Moreover, the major pathways involved are linked to ROS and free radical formation, alterations in ATP formation, calcium homeostasis, apoptosis, mitochondrial turnover and dynamics, and neuroinflammation in terms of microglia and astrocytes activation. These pathways are affected in all the neurodegenerative diseases discussed in this review. Increase of ROS is represented by the black arrow pointing up and reduction in energy production by the black arrow pointing down. Created with BioRender software.
Figure 2 The process of neurodegeneration in the central nervous system (CNS), in the periphery and across diseases. Neurodegeneration is a progressive process taking place not only in the CNS but also in the periphery. After the accumulation of damage at the cellular and, in particular, mitochondrial level, the switch from physiology to pathology is fast and rarely reversible and it is occurring in many cell types. Indeed, it occurs in the CNS but also in the periphery, in particular the neuromuscular junction (NMJ), the skeletal muscles, blood cells, and fibroblasts. Moreover, the major pathways involved are linked to ROS and free radical formation, alterations in ATP formation, calcium homeostasis, apoptosis, mitochondrial turnover and dynamics, and neuroinflammation in terms of microglia and astrocytes activation. These pathways are affected in all the neurodegenerative diseases discussed in this review. Increase of ROS is represented by the black arrow pointing up and reduction in energy production by the black arrow pointing down. Created with BioRender software.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 242 references

Cited by

See all 93

Metadata

Authors
Stanga, S., Caretto, A., Boido, M., & Vercelli, A.
Affiliations
Neuroscience Institute Cavalieri Ottolenghi (IT)
Corresponding author
Stanga, Serena
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2020-05-25
Volume
21
Issue
10
Pages
3719
ISSN
1422-0067 (ISSN-L)
OpenAlex
W3026090014
Cited by
90
References
244
Citations by year
2026: 7 · 2025: 14 · 2024: 10 · 2023: 8 · 2022: 18 · 2021: 23 · 2020: 10
FWCI
1.41
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Ministero dell’Istruzione, dell’Università e della Ricerca (“Dipartimenti di Eccellenza 2018–2022” to Department of Neuroscience “Rita Levi Montalcini)
  • Fondazione CRT (RF 2017.2052)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Keywords
mitochondrial dysfunction, neurodegenerative diseases, neurodegeneration, Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, spinal muscular atrophy, mitochondrial morphology, mitochondrial-targeted drugs, cellular senescence, DNA damage
MeSH terms
Alzheimer Disease, Amyotrophic Lateral Sclerosis, Animals, Antioxidants, Organelle Biogenesis, Humans, Mitochondria, Muscular Atrophy, Spinal, Parkinson Disease, Neuroprotective Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mitochondrial Dysfunctions: A Red Thread across Neurodegenerative Diseases. https://app.cochat.ai/papers/10.3390/ijms21103719
The paper
Stanga, S., Caretto, A., Boido, M., & Vercelli, A. (2020). Mitochondrial Dysfunctions: A Red Thread across Neurodegenerative Diseases. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms21103719

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.